Exosomes are cell-derived vesicles containing heterogeneous active biomolecules such as
proteins, lipids, mRNAs, receptors, immune regulatory molecules, and nucleic acids. They
typically range in size from 30 to 150 nm in diameter. An exosome’s surfaces can
be bioengineered with antibodies, fluorescent dye, peptides, and tailored for small
molecule and large active biologics. Exosomes have enormous potential as a drug delivery
vehicle due to enhanced biocompatibility, excellent payload capability, and reduced
immunogenicity compared to alternative polymeric-based carriers. Because of active
targeting and specificity, exosomes are capable of delivering their cargo to
exosome-recipient cells. Additionally, exosomes can potentially act as early stage
disease diagnostic tools as the exosome carries various protein biomarkers associated
with a specific disease. In this review, we summarize recent progress on exosome
composition, biological characterization, and isolation techniques. Finally, we outline
the exosome’s clinical applications and preclinical advancement to provide an
outlook on the importance of exosomes for use in targeted drug delivery, biomarker
study, and vaccine development.